// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Characteristics and treatment regimens across ERS SHARP severe asthma registries

Job J.M.H. van Bragt - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD

Alessia Vignoli - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

beclomethasone dipropionate/formoterol (NEXT DPI)

Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial

Peter M.A. Calverley - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients

Yousef S Aldabayan - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Arterial stiffness

N/A

Target Oximetry in babies with Bronchopulmonary Dysplasia at Cessation of Oxygen Therapy

Khaing Thu Thu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Development of pathway for transition of patients on long term ventilation from paediatric to adult service

Kamini Jain - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Humidified high flow oxygen in paediatrics: who, when and where; a service evaluation

Christopher Edwards - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fractional exhaled nitric oxide in preterm-born subjects: A systematic review and meta-analysis

Sarah Kotecha - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nitric oxide

Diuretic use and duration of home oxygen therapy in infants with Bronchopulmonary Dysplasia (BPD)

Yung Ci Chai - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Prediction of mortality in newborn infants with severe congenital diaphragmatic hernia using the chest radiographic thoracic area

Theodore Dassios - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Congenital diaphragmatic hernia

N/A

Late Breaking Abstract - Predicting long term lung function outcomes of prematurely born infants using cluster analysis

Christopher Harris - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Influence of caffeine on the electrical activity of the diaphragm of mechanically ventilated, very premature infants

Emma Williams - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Caffeine

Late Breaking Abstract - Cost-effectiveness of outpatient (OP) vs. inpatient (IP) setup of home non-invasive ventilation (NIV) in obesity hypoventilation syndrome (OHS): A Randomised Clinical Trial

Patrick B. Murphy - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Obesity hypoventilation syndrome

N/A

Screening for Sleep-Disordered Breathing in Patients Awaiting Bariatric Surgery: Comparison between two European Centres

Katarzyna Mycroft - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Review of acute NIV outcomes over five years in a university hospital

Nilaani Murugesu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of healthcare reorganisation in England on local home non-invasive ventilation (NIV) demand

John Seymour - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute NIV in presumed ECOPD without previous spirometry

Nicholas Lane - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Home non-invasive ventilation (NIV) for chronic obstructive pulmonary disease (COPD) after hypercapnic exacerbation: does local practice reflect evidence?

John Seymour - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Home mechanical ventilation in chronic respiratory failure: 10-year mortality

Esther Irene Schwarz - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Traumatic spinal cord injury

N/A

Delays to Non-Invasive Ventilation (NIV) are still happening. Why do clinicians in a tertiary hospital continue to do this?

Mark Nugent - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved